{"id":6118,"date":"2024-05-28T10:30:56","date_gmt":"2024-05-28T08:30:56","guid":{"rendered":"https:\/\/hemerion.com\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/"},"modified":"2024-05-28T10:52:08","modified_gmt":"2024-05-28T08:52:08","slug":"premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance","status":"publish","type":"post","link":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/","title":{"rendered":"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Un premier patient a \u00e9t\u00e9 trait\u00e9 \u00e0 Pittsburgh, Pennsylvanie, aux \u00c9tats-Unis d\u00e9but avril 2024 dans le cadre du nouvel essai clinique sponsoris\u00e9 par Hemerion.<\/strong><br\/><strong>Cette \u00e9tude (HTX-GBM-01) est con\u00e7ue pour confirmer l&rsquo;innocuit\u00e9 et la faisabilit\u00e9 de la th\u00e9rapie combin\u00e9e Pentalafen\u00ae \/ Heliance\u00ae dans le traitement du glioblastome, la forme la plus r\u00e9pandue et la plus agressive de cancer du cerveau. C&rsquo;est la premi\u00e8re fois que cette th\u00e9rapie est utilis\u00e9e dans une salle d&rsquo;op\u00e9ration aux \u00c9tats-Unis. <\/strong><\/p>\n\n<h3 class=\"wp-block-heading\">Pentalafen\u00ae \/ Heliance\u00ae : une solution th\u00e9rapeutique compl\u00e9mentaire aux traitements existants, pour am\u00e9liorer la survie et la qualit\u00e9 de vie des patients<\/h3>\n\n<p class=\"wp-block-paragraph\">Hemerion d\u00e9veloppe une solution th\u00e9rapeutique qui associe un m\u00e9dicament photosensibilisateur (le Pentalafen\u00ae) et une plateforme d&rsquo;illumination (Heliance\u00ae).<\/p>\n\n<p class=\"wp-block-paragraph\">Cette th\u00e9rapie combin\u00e9e est utilis\u00e9e au bloc op\u00e9ratoire imm\u00e9diatement apr\u00e8s la r\u00e9section de la tumeur, pour d\u00e9truire le maximum de cellules canc\u00e9reuses dans les profondeurs des tissus, sans endommager les cellules saines. Elle pourrait r\u00e9duire significativement le risque de r\u00e9cidive et am\u00e9liorer la survie et la qualit\u00e9 de vie des patients. <\/p>\n\n<h3 class=\"wp-block-heading\">Une avanc\u00e9e clinique majeure<\/h3>\n\n<p class=\"wp-block-paragraph\">Cet essai clinique, clinique est con\u00e7u pour confirmer l&rsquo;innocuit\u00e9 et la faisabilit\u00e9 de la th\u00e9rapie photodynamique perop\u00e9ratoire (PDT), utilisant le m\u00e9dicament Pentalafen\u00ae et le dispositif Heliance\u00ae. De plus, l&rsquo;\u00e9tude \u00e9valuera l&rsquo;efficacit\u00e9 de l&rsquo;augmentation des doses de lumi\u00e8re pour optimiser les param\u00e8tres de la th\u00e9rapie. <\/p>\n\n<p class=\"wp-block-paragraph\">C&rsquo;est une \u00e9tape cruciale pour pr\u00e9parer l&rsquo;\u00e9tude pivot qui confirmera l&rsquo;efficacit\u00e9 th\u00e9rapeutique du traitement et ouvrira la voie \u00e0 son utilisation comme nouvelle norme de soins.<\/p>\n\n<h3 class=\"wp-block-heading\">Une premi\u00e8re aux Etats-Unis<\/h3>\n\n<p class=\"wp-block-paragraph\">L&rsquo;essai clinique est r\u00e9alis\u00e9 dans deux h\u00f4pitaux de l\u2019Universit\u00e9 de Pittsburgh : le Presbyterian Hospital et le Hillman Cancer Center.<\/p>\n\n<p class=\"wp-block-paragraph\">Le premier patient inclus dans l\u2019essai a subi une intervention chirurgicale d&rsquo;ex\u00e9r\u00e8se de la tumeur le 11 avril 2024. C&rsquo;est la toute premi\u00e8re fois que la combinaison Pentalafen\u00ae\/Heliance\u00ae est utilis\u00e9e aux \u00c9tats-Unis. <\/p>\n\n<p class=\"wp-block-paragraph\">L&rsquo;op\u00e9ration a \u00e9t\u00e9 pr\u00e9par\u00e9e de longue date par l&rsquo;\u00e9quipe Hemerion avec la mise en place de la derni\u00e8re version de la th\u00e9rapie Pentalafen\u00ae\/Heliance\u00ae aux \u00c9tats-Unis.<\/p>\n\n<p class=\"wp-block-paragraph\">Hemerion a aussi form\u00e9 les \u00e9quipes de neuro-oncologie et de neurochirurgie mobilis\u00e9es sur l\u2019essai clinique.<\/p>\n\n<p class=\"wp-block-paragraph\">Ces \u00e9quipes sont dirig\u00e9es par Jan Drappatz, M.D., directeur du Programme de Neuro-oncologie \u00e0 l&rsquo;UPMC et Professeur Associ\u00e9 \u00e0 l&rsquo;\u00c9cole de M\u00e9decine de l&rsquo;Universit\u00e9 de Pittsburgh, et Costas Hadjipanayis, M.D., Ph.D., vice-pr\u00e9sident ex\u00e9cutif de la Neurochirurgie de l&rsquo;Universit\u00e9 de Pittsburgh, directeur du Centre UPMC pour la Neurochirurgie Guid\u00e9e par l&rsquo;Image et co-directeur du Programme des Tumeurs C\u00e9r\u00e9brales du d\u00e9partement.<\/p>\n\n<p class=\"wp-block-paragraph\">La proc\u00e9dure th\u00e9rapeutique se d\u00e9roule en deux temps :<\/p>\n\n<ul class=\"wp-block-list\">\n<li>La prise du Pentalafen\u00ae par le patient, r\u00e9alis\u00e9e six heures avant la chirurgie.<\/li>\n\n\n\n<li>Apr\u00e8s l&rsquo;ablation de la tumeur, la mise en place de la s\u00e9quence d&rsquo;illumination, y compris la dosim\u00e9trie, la s\u00e9quence d&rsquo;illumination et le positionnement du diffuseur dans la cavit\u00e9 chirurgicale.<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Les prochains patients seront inclus dans les semaines \u00e0 venir, au terme de la p\u00e9riode d&rsquo;observation pr\u00e9vue apr\u00e8s le premier traitement.<\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<p class=\"wp-block-paragraph\"><em>\u00ab\u00a0Notre \u00e9quipe \u00e9tait impatiente d&rsquo;\u00e9tendre les essais cliniques aux \u00c9tats-Unis, vus les r\u00e9sultats prometteurs des premi\u00e8res \u00e9tudes men\u00e9es en France depuis 2017. Si elle est approuv\u00e9e, nous pensons que cette th\u00e9rapie pourrait repr\u00e9senter une v\u00e9ritable source d&rsquo;espoir pour nos patients et leurs familles.\u00a0\u00bb<\/em><\/p>\n\n<div class=\"wp-block-media-text is-stacked-on-mobile is-vertically-aligned-center\" style=\"grid-template-columns:15% auto\"><figure class=\"wp-block-media-text__media\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"700\" height=\"780\" src=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/dr-jan-drappatz.jpg?resize=700%2C780&#038;ssl=1\" alt=\"Dr. Jan Drappatz\" class=\"wp-image-6083 size-full\" srcset=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/dr-jan-drappatz.jpg?w=700&amp;ssl=1 700w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/dr-jan-drappatz.jpg?resize=269%2C300&amp;ssl=1 269w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"wp-block-paragraph\"><strong><strong><strong>Dr. Jan Drappatz, MD &#8211; Neuro-oncologue<br\/>Directeur du programme de neuro-oncologie. Associate Professor de la Facult\u00e9 de M\u00e9decine &#8211; Universit\u00e9 de Pittsburgh. Investigateur principal de l\u2019essai clinique, UPMC<\/strong><\/strong><\/strong><\/p>\n<\/div><\/div>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n<p class=\"wp-block-paragraph\"><em>\u00ab\u00a0Compte tenu de son potentiel \u00e0 r\u00e9soudre la principale difficult\u00e9 \u00e0 laquelle les \u00e9quipes de neurochirurgie sont confront\u00e9es, \u00e0 savoir l&rsquo;\u00e9radication des cellules canc\u00e9reuses infiltrantes \u00e0 proximit\u00e9 de la cavit\u00e9 op\u00e9ratoire, nous avons bon espoir que cette nouvelle technologie am\u00e9liorera significativement les r\u00e9sultats de la chirurgie du glioblastome.\u00a0\u00bb<\/em><\/p>\n\n<div class=\"wp-block-media-text is-stacked-on-mobile is-vertically-aligned-center\" style=\"grid-template-columns:15% auto\"><figure class=\"wp-block-media-text__media\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"700\" height=\"780\" src=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/dr-costas-hadjipanayis.jpg?resize=700%2C780&#038;ssl=1\" alt=\"Dr. Costas Hadjipanayis\" class=\"wp-image-6085 size-full\" srcset=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/dr-costas-hadjipanayis.jpg?w=700&amp;ssl=1 700w, https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/dr-costas-hadjipanayis.jpg?resize=269%2C300&amp;ssl=1 269w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"wp-block-paragraph\"><strong>Dr. Costas Hadjipanayis, MD, PhD, Neurochirurgien<\/strong><br\/><strong>Vice-Pr\u00e9sident &#8211; UPMC Neurological Surgery. Directeur du Centre de Neurochirurgie Guid\u00e9e par l\u2019Image. Co-Directeur du Programme des Tumeurs C\u00e9r\u00e9brales. Co-investigateur de l\u2019essai clinique, UPMC<\/strong><\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Un premier patient a \u00e9t\u00e9 trait\u00e9 \u00e0 Pittsburgh, Pennsylvanie, aux \u00c9tats-Unis d\u00e9but avril 2024 dans le cadre du nouvel essai clinique sponsoris\u00e9 par Hemerion.Cette \u00e9tude (HTX-GBM-01) est con\u00e7ue pour confirmer l&rsquo;innocuit\u00e9 et la faisabilit\u00e9 de la th\u00e9rapie combin\u00e9e Pentalafen\u00ae \/ Heliance\u00ae dans le traitement du glioblastome, la forme la plus r\u00e9pandue et la plus agressive &#8230; <\/p>\n<p class=\"read-more-container\"><a title=\"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae\" class=\"read-more button\" href=\"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/#more-6118\" aria-label=\"En savoir plus sur Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae\">Lire plus<\/a><\/p>\n","protected":false},"author":207845438,"featured_media":6116,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_jet_sm_ready_style":"","_jet_sm_style":"","_jet_sm_controls_values":"","_jet_sm_fonts_collection":"","_jet_sm_fonts_links":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_wpcom_ai_launchpad_first_post":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[6342],"tags":[],"class_list":["post-6118","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae - Hemerion<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae - Hemerion\" \/>\n<meta property=\"og:description\" content=\"Un premier patient a \u00e9t\u00e9 trait\u00e9 \u00e0 Pittsburgh, Pennsylvanie, aux \u00c9tats-Unis d\u00e9but avril 2024 dans le cadre du nouvel essai clinique sponsoris\u00e9 par Hemerion.Cette \u00e9tude (HTX-GBM-01) est con\u00e7ue pour confirmer l&rsquo;innocuit\u00e9 et la faisabilit\u00e9 de la th\u00e9rapie combin\u00e9e Pentalafen\u00ae \/ Heliance\u00ae dans le traitement du glioblastome, la forme la plus r\u00e9pandue et la plus agressive ... Lire plus\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/\" \/>\n<meta property=\"og:site_name\" content=\"Hemerion\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-28T08:30:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-28T08:52:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/operating-room-3.jpg?fit=2000%2C1328&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1328\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Simon Delmotte\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HemerionTx\" \/>\n<meta name=\"twitter:site\" content=\"@HemerionTx\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Delmotte\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/\"},\"author\":{\"name\":\"Simon Delmotte\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/person\\\/ec5b45c7f7f52200ee5073ce247a86c7\"},\"headline\":\"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \\\/ Heliance\u00ae\",\"datePublished\":\"2024-05-28T08:30:56+00:00\",\"dateModified\":\"2024-05-28T08:52:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/\"},\"wordCount\":734,\"publisher\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/operating-room-3.jpg?fit=2000%2C1328&ssl=1\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/\",\"name\":\"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \\\/ Heliance\u00ae - Hemerion\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/operating-room-3.jpg?fit=2000%2C1328&ssl=1\",\"datePublished\":\"2024-05-28T08:30:56+00:00\",\"dateModified\":\"2024-05-28T08:52:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/operating-room-3.jpg?fit=2000%2C1328&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/operating-room-3.jpg?fit=2000%2C1328&ssl=1\",\"width\":2000,\"height\":1328,\"caption\":\"Operating room\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \\\/ Heliance\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"name\":\"Hemerion\",\"description\":\"Advancing cancer therapies at the speed of light\",\"publisher\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#organization\",\"name\":\"Hemerion\",\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/hemerion.com\\\/wp-content\\\/uploads\\\/hemerion-logo.png?fit=1581%2C460&ssl=1\",\"width\":1581,\"height\":460,\"caption\":\"Hemerion\"},\"image\":{\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/HemerionTx\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hemerion-therapeutics\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCWwcUj-aSdo32OYwN5vjf8Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/#\\\/schema\\\/person\\\/ec5b45c7f7f52200ee5073ce247a86c7\",\"name\":\"Simon Delmotte\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g\",\"caption\":\"Simon Delmotte\"},\"url\":\"https:\\\/\\\/hemerion.com\\\/fr\\\/author\\\/simondelmotte\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae - Hemerion","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/","og_locale":"fr_FR","og_type":"article","og_title":"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae - Hemerion","og_description":"Un premier patient a \u00e9t\u00e9 trait\u00e9 \u00e0 Pittsburgh, Pennsylvanie, aux \u00c9tats-Unis d\u00e9but avril 2024 dans le cadre du nouvel essai clinique sponsoris\u00e9 par Hemerion.Cette \u00e9tude (HTX-GBM-01) est con\u00e7ue pour confirmer l&rsquo;innocuit\u00e9 et la faisabilit\u00e9 de la th\u00e9rapie combin\u00e9e Pentalafen\u00ae \/ Heliance\u00ae dans le traitement du glioblastome, la forme la plus r\u00e9pandue et la plus agressive ... Lire plus","og_url":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/","og_site_name":"Hemerion","article_published_time":"2024-05-28T08:30:56+00:00","article_modified_time":"2024-05-28T08:52:08+00:00","og_image":[{"width":2000,"height":1328,"url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/operating-room-3.jpg?fit=2000%2C1328&ssl=1","type":"image\/jpeg"}],"author":"Simon Delmotte","twitter_card":"summary_large_image","twitter_creator":"@HemerionTx","twitter_site":"@HemerionTx","twitter_misc":{"\u00c9crit par":"Simon Delmotte","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/#article","isPartOf":{"@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/"},"author":{"name":"Simon Delmotte","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/person\/ec5b45c7f7f52200ee5073ce247a86c7"},"headline":"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae","datePublished":"2024-05-28T08:30:56+00:00","dateModified":"2024-05-28T08:52:08+00:00","mainEntityOfPage":{"@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/"},"wordCount":734,"publisher":{"@id":"https:\/\/hemerion.com\/fr\/#organization"},"image":{"@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/operating-room-3.jpg?fit=2000%2C1328&ssl=1","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/","url":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/","name":"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae - Hemerion","isPartOf":{"@id":"https:\/\/hemerion.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/#primaryimage"},"image":{"@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/operating-room-3.jpg?fit=2000%2C1328&ssl=1","datePublished":"2024-05-28T08:30:56+00:00","dateModified":"2024-05-28T08:52:08+00:00","breadcrumb":{"@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/#primaryimage","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/operating-room-3.jpg?fit=2000%2C1328&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/operating-room-3.jpg?fit=2000%2C1328&ssl=1","width":2000,"height":1328,"caption":"Operating room"},{"@type":"BreadcrumbList","@id":"https:\/\/hemerion.com\/fr\/premier-patient-traite-aux-etats-unis-avec-la-therapie-pentalafen-heliance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hemerion.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Premier patient trait\u00e9 aux \u00c9tats-Unis avec la th\u00e9rapie Pentalafen\u00ae \/ Heliance\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/hemerion.com\/fr\/#website","url":"https:\/\/hemerion.com\/fr\/","name":"Hemerion","description":"Advancing cancer therapies at the speed of light","publisher":{"@id":"https:\/\/hemerion.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hemerion.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/hemerion.com\/fr\/#organization","name":"Hemerion","url":"https:\/\/hemerion.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","contentUrl":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/hemerion-logo.png?fit=1581%2C460&ssl=1","width":1581,"height":460,"caption":"Hemerion"},"image":{"@id":"https:\/\/hemerion.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/HemerionTx","https:\/\/www.linkedin.com\/company\/hemerion-therapeutics\/","https:\/\/www.youtube.com\/channel\/UCWwcUj-aSdo32OYwN5vjf8Q"]},{"@type":"Person","@id":"https:\/\/hemerion.com\/fr\/#\/schema\/person\/ec5b45c7f7f52200ee5073ce247a86c7","name":"Simon Delmotte","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2f742e1ce87613e0ccca0877b0360f87beea918ba8e5efe3717e2c5285bfdc28?s=96&d=identicon&r=g","caption":"Simon Delmotte"},"url":"https:\/\/hemerion.com\/fr\/author\/simondelmotte\/"}]}},"jetpack_shortlink":"https:\/\/wp.me\/pd9WhZ-1AG","jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/hemerion.com\/wp-content\/uploads\/operating-room-3.jpg?fit=2000%2C1328&ssl=1","_links":{"self":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/6118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/users\/207845438"}],"replies":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/comments?post=6118"}],"version-history":[{"count":3,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/6118\/revisions"}],"predecessor-version":[{"id":6121,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/posts\/6118\/revisions\/6121"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media\/6116"}],"wp:attachment":[{"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/media?parent=6118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/categories?post=6118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hemerion.com\/fr\/wp-json\/wp\/v2\/tags?post=6118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}